1. 方法論と範囲
1.1. 調査方法
1.2. 調査目的と調査範囲
2. 定義と概要
3. エグゼクティブ・サマリー
3.1. 製品タイプ別スニペット
3.2. 投与経路別スニペット
3.3. 用途別スニペット
3.4. エンドユーザー別スニペット
3.5. 地域別スニペット
4. ダイナミクス
4.1. 影響要因
4.1.1. 推進要因
4.1.1.1. 慢性疾患の増加と技術の進歩
4.1.1.2. XX
4.1.2. 阻害要因
4.1.2.1. 先端技術の高コスト
4.1.3. 機会
4.1.4. 影響分析
5. 産業分析
5.1. ポーターのファイブフォース分析
5.2. サプライチェーン分析
5.3. 価格分析
5.4. 規制分析
6. 製品タイプ別
6.1. 製品紹介
6.1.1. 製品タイプ別市場規模分析および前年比成長率分析(%)
6.1.2. 市場魅力度指数（製品タイプ別
6.2. 輸液ポンプ
6.2.1. 序論
6.2.2. 市場規模分析と前年比成長率分析(%)
6.3. 点滴セット
6.4. 点滴カニューレ
6.5. ニードルレスコネクター
6.6. 静脈画像診断装置
7. 投与経路別
7.1. はじめに
7.1.1. 市場規模分析および前年比成長率分析（%）、投与経路別
7.1.2. 市場魅力度指数（投与経路別
7.2. 筋肉内投与
7.2.1. はじめに
7.2.2. 市場規模分析と前年比成長率分析(%)
7.3. 皮下
7.4. 硬膜外
8. 用途別
8.1. 導入
8.1.1. 用途別市場規模分析および前年比成長率分析(%)
8.1.2. 市場魅力度指数（流通チャネル別
8.2. 抗生物質とウイルス
8.2.1. はじめに
8.2.2. 市場規模分析と前年比成長率分析(%)
8.3. 強心療法
8.4. 抗凝固療法
8.5. 化学療法
8.6. 栄養療法
8.7. 血液成分
8.8. その他
9. エンドユーザー別
9.1. 導入
9.1.1. 市場規模分析および前年比成長率分析(%), エンドユーザー別
9.1.2. 市場魅力度指数、エンドユーザー別
9.2. 病院・専門クリニック
9.2.1. はじめに
9.2.2. 市場規模分析と前年比成長率分析(%)
9.3. 外来手術センター
9.4. 在宅介護施設
10. 地域別
10.1. はじめに
10.1.1. 地域別市場規模分析および前年比成長率分析(%)
10.1.2. 市場魅力度指数、地域別
10.2. 北米
10.2.1. 序論
10.2.2. 主な地域別ダイナミクス
10.2.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
10.2.4. 市場規模分析および前年比成長率分析（%）、投与経路別
10.2.5. 市場規模分析および前年比成長率分析（%）, 用途別
10.2.6. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
10.2.7. 市場規模分析および前年比成長率分析(%)、国別
10.2.7.1. 米国
10.2.7.2. カナダ
10.2.7.3. メキシコ
10.3. ヨーロッパ
10.3.1. はじめに
10.3.2. 主な地域別ダイナミクス
10.3.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
10.3.4. 市場規模分析および前年比成長率分析（%）、投与経路別
10.3.5. 市場規模分析および前年比成長率分析（%）, 用途別
10.3.6. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
10.3.7. 市場規模分析および前年比成長率分析(%)、国別
10.3.7.1. ドイツ
10.3.7.2. イギリス
10.3.7.3. フランス
10.3.7.4. スペイン
10.3.7.5. イタリア
10.3.7.6. その他のヨーロッパ
10.4. 南米
10.4.1. はじめに
10.4.2. 地域別主要市場
10.4.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
10.4.4. 市場規模分析と前年比成長率分析(%)、製品タイプ別
10.4.5. 市場規模分析および前年比成長率分析（%）、投与経路別
10.4.6. 市場規模分析および前年比成長率分析（%）, 用途別
10.4.7. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
10.4.8. 市場規模分析および前年比成長率分析(%)、国別
10.4.9. ブラジル
10.4.10. アルゼンチン
10.4.11. その他の南米諸国
10.5. アジア太平洋
10.5.1. 序論
10.5.2. 主な地域別ダイナミクス
10.5.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
10.5.4. 市場規模分析および前年比成長率分析（%）、投与経路別
10.5.5. 市場規模分析および前年比成長率分析（%）, 用途別
10.5.6. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
10.5.7. 市場規模分析および前年比成長率分析(%)、国別
10.5.7.1. 中国
10.5.7.2. インド
10.5.7.3. 日本
10.5.7.4. 韓国
10.5.7.5. その他のアジア太平洋地域
10.6. 中東・アフリカ
10.6.1. 序論
10.6.2. 主な地域別ダイナミクス
10.6.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
10.6.4. 市場規模分析および前年比成長率分析（%）、投与経路別
10.6.5. 市場規模分析および前年比成長率分析（%）, 用途別
10.6.6. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
11. 競合情勢
11.1. 競争シナリオ
11.2. 市場ポジショニング／シェア分析
11.3. M&A分析
12. 企業プロフィール
12.1. B. Braun Melsungen AG*
12.1.1. 会社概要
12.1.2. 製品ポートフォリオと内容
12.1.3. 財務概要
12.1.4. 主な展開
12.2. ICU Medical, Inc.
12.3. Baxter International Inc.
12.4. Fresenius Kabi AG
12.5. Terumo Corporation
12.6. Becton, Dickinson and Company
12.7. Nipro Corporation
12.8. Mindray Medical India Pvt. Ltd.
12.9. Moog Inc.
12.10. Teleflex Incorporated (*リストは除外)
13. 付録
13.1. テレフレックスについて
13.2. お問い合わせ
The Global Infusion Therapy Market reached US$ 43.5 billion in 2023 and is expected to reach US$ 73.7 billion by 2031 growing with a CAGR of 6.8% during the forecast period 2024-2031.
Infusion therapy, also known as intravenous (IV) therapy, is a medical procedure that involves delivering medications, fluids, or nutrients directly into a patient's bloodstream through a needle or catheter. This method is primarily used to provide immediate and effective treatment for various medical conditions.
Infusion therapy serves as a safer alternative to oral medication, particularly for patients who have difficulty swallowing. It is also beneficial in situations where stomach acids could compromise the effectiveness of certain medications, rendering them less effective. Infusion therapy is crucial for managing medical conditions that necessitate precise dosing and uninterrupted medication administration. The ability to deliver medications continuously and accurately is vital for effectively treating various health issues.
Market Dynamics: Drivers
Rising prevalence of chronic diseases and technological advancements
The demand for the global infusion therapy market is driven by multiple factors. One of the primary factors is the rising prevalence of chronic diseases and technological advancements. The rising incidence of chronic conditions such as diabetes, cancer, and cardiovascular diseases significantly drives the infusion therapy market. These diseases often require long-term management and precise medication delivery, which makes infusion therapies increasingly essential.
According to the World Health Organization (WHO) data in 2024, indicates that cardiovascular diseases are the leading cause of death worldwide, responsible for approximately 17.9 million fatalities each year. Infusion therapy plays a vital role in managing conditions like heart failure, where continuous medication delivery is essential for achieving optimal patient outcomes.
Innovations in infusion devices, particularly the development of smart infusion pumps that integrate with electronic health records (EHRs) for real-time monitoring, are significantly enhancing patient safety and treatment efficacy. These advancements are transforming the landscape of infusion therapy, making it more efficient and user-friendly, which would propel market growth.
Moreover, key players in the industry's technological advancements such as the introduction of innovative treatments for chronic diseases and launching advanced software propel this market growth. For instance, in February 2024, the NHS launched a new treatment for advanced Parkinson's disease known as foslevodopa-foscarbidopa, also referred to as Produodopa. This innovative therapy is designed for patients whose symptoms are not adequately managed by traditional oral medications. It involves a portable, wearable infusion system that continuously delivers medication through a small pump worn under the skin, allowing for 24-hour symptom management.
Similarly, in June 2023, B. Braun Medical Inc. unveiled its latest infusion management software, DoseTrac Enterprise Infusion Management Software, aimed at enhancing the management of infusion pumps within healthcare organizations. This advanced software provides a combination of real-time monitoring and retrospective reporting capabilities, allowing organizations to gain deeper insights into their infusion pump fleet and the associated data.
Restraints
Factors such as the high cost of advanced technologies, risk & complexity of devices, and regulatory & reimbursement challenges are expected to hamper the market.
Market Segment Analysis
The global infusion therapy market is segmented based on product type, route of administration, application, end-user, and region.
The infusion pumps segment accounted for approximately 52.1% of the global infusion therapy market share
The infusion pumps segment is expected to hold the largest market share over the forecast period. The growing need for accurate and efficient medication delivery systems has led to a rise in the use of infusion pumps. These devices are specifically designed to administer fluids, medications, or nutrients to patients in regulated doses, making them crucial for a wide range of medical applications.
The infusion pumps segment is marked by ongoing technological advancements that significantly enhance patient safety and treatment effectiveness. One of the most notable innovations is the development of smart infusion pumps, which integrate seamlessly with electronic health records (EHRs) to facilitate real-time monitoring of patient data.
Smart infusion pumps with electronic health record (EHR) integration offer a significant improvement in patient safety by minimizing the risk of medication administration errors. This technology allows for the automatic transmission of medication orders directly from the EHR to the infusion pump, eliminating the need for manual programming and reducing the potential for human error.
Moreover, key players in the industry product launches and Key Developments in the infusion pumps are driving this segment growth in the market. For instance, in February 2023, Mindray launched the BeneFusion i Series and u Series infusion systems marking a significant advancement in infusion technology, emphasizing high precision, adaptive customization, and user-friendly interfaces to enhance medication safety across various clinical settings. This development aligns with the growing trend of adopting smart infusion pumps, which have evolved from basic mechanical devices to sophisticated systems designed to minimize medication errors and improve patient outcomes.
Similarly, in April 2023, Eitan Medical introduced the Avoset Infusion System, a cutting-edge connected ambulatory infusion pump designed to enhance post-acute care and specialty infusion therapy. This innovative system focuses on improving patient safety and user experience through its compact design and advanced technology.
Market Geographical Analysis
North America accounted for approximately 44.6% of the global infusion therapy market share
North America region is expected to hold the largest market share over the forecast period owing to the increasing incidence of chronic diseases such as cancer, diabetes, and cardiovascular conditions significantly driving the demand for infusion therapy in North America.
According to the American Cancer Society, around 1.9 million new cancer cases were diagnosed in the United States in 2021. Many individuals diagnosed with cancer require infusion therapy for treatments such as chemotherapy and other supportive care, which leads to an increased demand for related products and services.
Similarly, American Hospital Association, stated that around 133 million people in the United States, which is nearly half the population, suffer from at least one chronic condition, such as hypertension, heart disease, or arthritis. This number is expected to rise to approximately 170 million by the year 2030, underscoring the increasing burden that chronic diseases place on the healthcare system in the country.
Moreover, in this region, a major number of key player's presence, well-advanced healthcare infrastructure, technological advancements, government favorable reimbursement policies, growing demand for home healthcare services, product launches, and approvals would drive this market growth.
For instance, in April 2024, in Canada, Mackenzie Health's launch of the BD Alaris EMR Interoperability system represents a significant advancement in intravenous (IV) medication management. This innovative technology enables two-way communication between IV infusion pumps and the patient's electronic medical record (EMR), streamlining the infusion process and enhancing patient safety.
Also, in April 2024, Baxter International Inc. received FDA 510(k) clearance for its Novum IQ large volume infusion pump (LVP) equipped with Dose IQ Safety Software. This addition to the Novum IQ Infusion Platform, which already includes a syringe infusion pump (SYR), allows healthcare providers to utilize a unified system across various patient care environments. The Novum IQ platform enhances the user experience by integrating the LVP and SYR pumps, thereby alleviating the workload of non-critical tasks for clinicians. This integration facilitates a streamlined training process and reduces the cognitive load associated with managing multiple pump systems.
Market Segmentation
By Product Type
Infusion Pumps
Intravenous Sets
IV Cannulas
Needleless Connectors
Vein Imaging Devices
By Route of Administration
Intramuscular
Subcutaneous
Epidural
By Application
Antibiotic & Viral
Inotropic Therapy
Anti-coagulation
Chemotherapy
Nutritional Therapy
Blood Component
Others
By End-User
Hospitals & Specialty Clinics
Ambulatory Surgery Centers
Homecare Settings
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
South America
Brazil
Argentina
The rest of South America
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Middle East and Africa
Market Competitive Landscape
The major global players in the infusion therapy market include B. Braun Melsungen AG, ICU Medical, Inc., Baxter International Inc., Fresenius Kabi AG, Terumo Corporation, Becton, Dickinson and Company, Nipro Corporation, Mindray Medical India Pvt. Ltd., Moog Inc., and Teleflex Incorporated among others.
Key Developments
In January 2024, AbbVie launched Produodopa (foslevodopa/foscarbidopa), a continuous subcutaneous infusion therapy, for the treatment of advanced Parkinson's disease in the European Union. Produodopa is the first and only 24-hour levodopa-based subcutaneous infusion therapy approved for this indication in the EU.
In June 2023, Eitan Medical introduced Eitan Insights, a new cloud-based infusion management system tailored for home and specialty infusion needs. This innovative platform connects with Eitan Medical's infusion systems, including the Sapphire pump, which now features a universal plug-and-play cellular accessory called Sapphire Connect, and the Avoset pump, complemented by the AvosetGo app.
Why Purchase the Report?
To visualize the global infusion therapy market segmentation based on product type, route of administration, application, end-user, and region and understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of the infusion therapy market with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping is available in Excel consisting of key products of all the major players.
The global infusion therapy market report would provide approximately 70 tables, 68 figures, and 183 pages
Target Audience 2024
Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Route of Administration
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Prevalence of Chronic Diseases and Technological Advancements
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. High Cost of Advanced Technologies
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. By Product Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Infusion Pumps *
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Intravenous Sets
6.4. IV Cannulas
6.5. Needleless Connectors
6.6. Vein Imaging Devices
7. By Route of Administration
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
7.1.2. Market Attractiveness Index, By Route of Administration
7.2. Intramuscular *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Subcutaneous
7.4. Epidural
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Distribution Channels
8.2. Antibiotic & Viral *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Inotropic Therapy
8.4. Anti-coagulation
8.5. Chemotherapy
8.6. Nutritional Therapy
8.7. Blood Component
8.8. Others
9. By End-User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals & Specialty Clinics *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgery Centers
9.4. Homecare Settings
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.7.1. U.S.
10.2.7.2. Canada
10.2.7.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.7.1. Germany
10.3.7.2. U.K.
10.3.7.3. France
10.3.7.4. Spain
10.3.7.5. Italy
10.3.7.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.9. Brazil
10.4.10. Argentina
10.4.11. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. China
10.5.7.2. India
10.5.7.3. Japan
10.5.7.4. South Korea
10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. B. Braun Melsungen AG*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. ICU Medical, Inc.
12.3. Baxter International Inc.
12.4. Fresenius Kabi AG
12.5. Terumo Corporation
12.6. Becton, Dickinson and Company
12.7. Nipro Corporation
12.8. Mindray Medical India Pvt. Ltd.
12.9. Moog Inc.
12.10. Teleflex Incorporated (*LIST NOT EXHAUSTIVE)
13. Appendix
13.1. About Us and Services
13.2. Contact Us
❖ 世界の輸液療法市場に関するよくある質問(FAQ) ❖
・輸液療法の世界市場規模は？
→DataM Intelligence社は2023年の輸液療法の世界市場規模を435億米ドルと推定しています。
・輸液療法の世界市場予測は？
→DataM Intelligence社は2031年の輸液療法の世界市場規模を737億米ドルと予測しています。
・輸液療法市場の成長率は？
→DataM Intelligence社は輸液療法の世界市場が2024年～2031年に年平均6.8%成長すると予測しています。
・世界の輸液療法市場における主要企業は？
→DataM Intelligence社は「B. Braun Melsungen AG、ICU Medical, Inc.、Baxter International Inc.、Fresenius Kabi AG、Terumo Corporation、Becton, Dickinson and Company、Nipro Corporation、Mindray Medical India Pvt. Ltd.、Moog Inc.、Teleflex Incorporatedなど ...」をグローバル輸液療法市場の主要企業として認識しています。
※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、納品レポートの情報と少し異なる場合があります。
